Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Kairos Pharma (KAPA) Invested Capital (2024 - 2025)

Historic Invested Capital for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $6.0 million.

  • Kairos Pharma's Invested Capital changed N/A to $6.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $4.8 million for FY2024, which is N/A changed from last year.
  • Per Kairos Pharma's latest filing, its Invested Capital stood at $6.0 million for Q2 2025.
  • Kairos Pharma's Invested Capital's 5-year high stood at $7.1 million during Q1 2025, with a 5-year trough of $3.3 million in Q3 2024.